First Header Logo Second Header Logo

Cheryl Bushnell

Concepts (347)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
82
2019
543
17.910
Why?
Brain Ischemia
23
2018
132
5.370
Why?
Women's Health
13
2014
222
3.340
Why?
Ischemic Attack, Transient
12
2018
42
3.050
Why?
Pregnancy Complications, Cardiovascular
10
2018
21
2.670
Why?
Secondary Prevention
11
2018
61
2.430
Why?
Sex Characteristics
10
2018
177
2.390
Why?
Migraine Disorders
6
2014
61
2.180
Why?
Humans
112
2019
29158
1.820
Why?
Estrogen Replacement Therapy
8
2014
189
1.790
Why?
Female
84
2018
18849
1.730
Why?
Pregnancy Complications
6
2017
78
1.660
Why?
Risk Factors
40
2018
3708
1.590
Why?
Pregnancy
21
2018
749
1.510
Why?
Patient Discharge
10
2019
171
1.280
Why?
Patient Readmission
4
2018
103
1.180
Why?
Pre-Eclampsia
2
2018
52
1.070
Why?
Patient-Centered Care
3
2018
65
1.010
Why?
Aged
42
2018
10010
0.980
Why?
Anticoagulants
7
2018
133
0.930
Why?
Middle Aged
42
2018
11519
0.890
Why?
Hypertension, Pregnancy-Induced
2
2018
9
0.890
Why?
Postpartum Period
3
2018
32
0.870
Why?
Hospitals
6
2019
73
0.850
Why?
Venous Thrombosis
3
2018
47
0.830
Why?
United States
25
2019
3752
0.810
Why?
Primary Prevention
3
2014
50
0.800
Why?
Vasospasm, Intracranial
1
2019
10
0.800
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2017
142
0.800
Why?
Vasoconstriction
1
2019
41
0.790
Why?
Cerebrovascular Disorders
1
2019
56
0.770
Why?
Intracranial Thrombosis
3
2014
8
0.750
Why?
Hypertension
6
2018
985
0.740
Why?
Male
41
2018
18549
0.740
Why?
Subacute Care
1
2018
8
0.740
Why?
Brain Diseases
1
2018
37
0.700
Why?
Thrombolytic Therapy
1
2017
54
0.690
Why?
Vascular Diseases
2
2009
72
0.670
Why?
Practice Guidelines as Topic
5
2019
390
0.660
Why?
Research Design
5
2018
285
0.650
Why?
Nurse Practitioners
1
2016
8
0.640
Why?
Mobility Limitation
1
2017
183
0.630
Why?
Aged, 80 and over
18
2017
3908
0.630
Why?
Cardiovascular Diseases
7
2014
1096
0.630
Why?
Depression
4
2017
379
0.620
Why?
Patient Education as Topic
5
2018
237
0.610
Why?
Upper Extremity
1
2015
50
0.590
Why?
American Heart Association
7
2014
95
0.580
Why?
Antineoplastic Agents, Hormonal
2
2005
40
0.580
Why?
Severity of Illness Index
4
2014
900
0.580
Why?
Tamoxifen
2
2005
53
0.570
Why?
Lower Extremity
1
2015
74
0.570
Why?
Menopause
3
2017
86
0.570
Why?
Antidepressive Agents
2
2012
78
0.550
Why?
Societies, Medical
2
2019
148
0.550
Why?
Cerebral Hemorrhage
4
2018
50
0.540
Why?
Guidelines as Topic
1
2014
45
0.540
Why?
Registries
7
2017
305
0.530
Why?
Aspirin
6
2018
63
0.520
Why?
Atrial Fibrillation
5
2017
319
0.500
Why?
Hospitals, Community
1
2012
8
0.490
Why?
Hyperlipidemias
3
2014
55
0.470
Why?
Quality Assurance, Health Care
1
2012
66
0.470
Why?
Telemedicine
1
2012
53
0.460
Why?
Continuity of Patient Care
1
2012
58
0.460
Why?
Neurology
3
2012
39
0.460
Why?
Incidence
10
2018
1162
0.460
Why?
Cerebral Arteries
2
2014
17
0.450
Why?
Quality of Life
3
2017
866
0.450
Why?
Pulsatile Flow
3
2015
25
0.440
Why?
Depressive Disorder
1
2011
78
0.440
Why?
Premenstrual Syndrome
1
2010
3
0.440
Why?
Platelet Aggregation Inhibitors
5
2017
96
0.440
Why?
Antihypertensive Agents
4
2018
371
0.430
Why?
Risk
2
2008
309
0.420
Why?
Models, Statistical
1
2011
158
0.410
Why?
Treatment Outcome
12
2018
3153
0.410
Why?
Life Change Events
1
2009
19
0.390
Why?
Appointments and Schedules
1
2009
19
0.390
Why?
Puerperal Disorders
3
2017
6
0.390
Why?
Prognosis
7
2018
1426
0.390
Why?
Time Factors
12
2018
2091
0.390
Why?
Randomized Controlled Trials as Topic
4
2011
451
0.380
Why?
Prevalence
5
2018
965
0.370
Why?
Headache Disorders, Primary
1
2008
4
0.370
Why?
Healthcare Disparities
4
2017
127
0.370
Why?
Adult
16
2018
8705
0.360
Why?
Longitudinal Studies
9
2017
748
0.350
Why?
Hospitalization
5
2017
374
0.350
Why?
Thrombectomy
2
2018
56
0.350
Why?
Case-Control Studies
5
2014
931
0.340
Why?
Follow-Up Studies
7
2018
2175
0.330
Why?
Medication Adherence
4
2018
137
0.320
Why?
Somatoform Disorders
1
2005
7
0.320
Why?
Risk Assessment
11
2017
1362
0.320
Why?
Medicare
2
2019
181
0.310
Why?
Intracranial Hemorrhages
2
2017
32
0.310
Why?
Disability Evaluation
4
2017
223
0.310
Why?
Intracranial Arteriosclerosis
1
2005
11
0.300
Why?
Electroencephalography
1
2005
74
0.300
Why?
Seizures
1
2005
52
0.300
Why?
Clinical Trials as Topic
3
2015
326
0.300
Why?
Magnetic Resonance Imaging
6
2019
1246
0.300
Why?
Internship and Residency
1
2009
271
0.290
Why?
Retrospective Studies
6
2018
2962
0.290
Why?
Recovery of Function
4
2017
212
0.290
Why?
Tetrazoles
2
2015
101
0.290
Why?
Selective Estrogen Receptor Modulators
1
2004
29
0.290
Why?
Economics, Pharmaceutical
1
2004
5
0.280
Why?
Prospective Studies
8
2017
2028
0.280
Why?
Anticholesteremic Agents
1
2004
37
0.270
Why?
Estrogens
1
2005
200
0.270
Why?
Emergency Medical Services
2
2019
145
0.270
Why?
Age Factors
6
2012
1182
0.270
Why?
Thrombophilia
1
2003
8
0.270
Why?
Contraceptives, Oral, Hormonal
2
2018
7
0.260
Why?
North Carolina
5
2019
1734
0.260
Why?
Odds Ratio
6
2017
478
0.260
Why?
Patient Selection
3
2018
267
0.250
Why?
Homocysteine
1
2002
16
0.250
Why?
Caregivers
3
2018
79
0.250
Why?
Comorbidity
4
2014
550
0.240
Why?
Blood Coagulation Tests
1
2002
8
0.240
Why?
Blood Coagulation Disorders
1
2002
10
0.240
Why?
Predictive Value of Tests
5
2017
813
0.230
Why?
Mass Screening
1
2003
202
0.230
Why?
Estrogens, Conjugated (USP)
2
2014
125
0.220
Why?
Fibrinolytic Agents
2
2011
64
0.220
Why?
Breast Neoplasms
2
2005
730
0.220
Why?
Disabled Persons
2
2014
82
0.220
Why?
Activities of Daily Living
2
2014
237
0.210
Why?
Ultrasonography, Doppler, Transcranial
3
2015
26
0.210
Why?
Gene Expression
2
2012
342
0.210
Why?
Gene Expression Regulation
2
2014
493
0.210
Why?
Gene Expression Profiling
5
2014
346
0.200
Why?
Organizational Policy
1
2019
21
0.200
Why?
Prenatal Care
2
2017
33
0.200
Why?
Certification
1
2019
20
0.200
Why?
Linear Models
3
2017
453
0.200
Why?
Clinical Competence
1
2002
301
0.190
Why?
Pilot Projects
2
2012
472
0.190
Why?
Health Status Indicators
2
2009
75
0.190
Why?
Data Mining
1
2018
7
0.190
Why?
Health Policy
1
2019
72
0.180
Why?
Ethics, Research
1
2018
28
0.180
Why?
Drug Therapy, Combination
3
2014
301
0.180
Why?
Tissue Plasminogen Activator
1
2018
36
0.180
Why?
Syndrome
1
2018
67
0.180
Why?
Delivery, Obstetric
1
2018
49
0.180
Why?
Endarterectomy, Carotid
1
2017
27
0.180
Why?
Professional Practice
1
2017
25
0.180
Why?
Skilled Nursing Facilities
1
2017
8
0.180
Why?
Delivery of Health Care, Integrated
1
2018
25
0.180
Why?
Informed Consent
1
2018
55
0.180
Why?
Cardiomyopathies
1
2018
51
0.180
Why?
Public Health Practice
1
2017
10
0.170
Why?
Women's Rights
1
2017
4
0.170
Why?
Electronic Health Records
1
2018
114
0.170
Why?
Sex Distribution
2
2014
200
0.170
Why?
Myocardial Ischemia
1
2017
93
0.170
Why?
Chronic Disease
2
2015
384
0.170
Why?
Quality Indicators, Health Care
1
2017
55
0.160
Why?
Cohort Studies
3
2011
1751
0.160
Why?
African Americans
2
2015
1645
0.160
Why?
Expert Testimony
1
2015
11
0.160
Why?
Evidence-Based Medicine
3
2014
201
0.150
Why?
Home Care Services
1
2016
39
0.150
Why?
Health Status
3
2018
399
0.150
Why?
Uric Acid
1
2015
25
0.150
Why?
Educational Status
2
2014
171
0.150
Why?
Diagnosis, Differential
2
2009
510
0.150
Why?
Histoplasmosis
1
2015
2
0.150
Why?
Adolescent
6
2012
3176
0.150
Why?
Sex Factors
1
2017
694
0.150
Why?
Vasculitis
1
2015
24
0.150
Why?
Blood Pressure
3
2014
896
0.150
Why?
Leukoencephalopathies
1
2014
5
0.150
Why?
Basilar Artery
1
2014
8
0.150
Why?
Algorithms
1
2018
454
0.150
Why?
Middle Cerebral Artery
1
2014
11
0.140
Why?
Causality
1
2014
35
0.140
Why?
Coronary Disease
2
2008
239
0.140
Why?
Intracranial Embolism
1
2014
9
0.140
Why?
Health Services for the Aged
1
2014
28
0.140
Why?
Life Style
2
2014
375
0.140
Why?
Leukocytes
1
2014
49
0.140
Why?
Risk Adjustment
1
2014
27
0.140
Why?
Income
1
2014
41
0.140
Why?
Hypercholesterolemia
1
2014
61
0.140
Why?
Risk Reduction Behavior
1
2014
110
0.130
Why?
Employment
1
2014
47
0.130
Why?
Proportional Hazards Models
3
2017
769
0.130
Why?
Tomography, X-Ray Computed
1
2019
931
0.130
Why?
Ischemia
1
2014
87
0.130
Why?
Image Interpretation, Computer-Assisted
1
2014
115
0.130
Why?
Young Adult
2
2017
2425
0.120
Why?
Reperfusion
1
2012
14
0.120
Why?
Quality of Health Care
1
2014
147
0.120
Why?
Chromosomes, Human, Y
1
2012
3
0.120
Why?
Chromosomes, Human, X
1
2011
15
0.120
Why?
African Continental Ancestry Group
1
2013
413
0.120
Why?
Program Evaluation
1
2012
176
0.120
Why?
Feasibility Studies
1
2012
259
0.110
Why?
Brain
3
2015
969
0.110
Why?
Oligonucleotide Array Sequence Analysis
4
2012
167
0.110
Why?
Tryptamines
1
2010
3
0.110
Why?
Naproxen
1
2010
8
0.110
Why?
National Institutes of Health (U.S.)
1
2010
27
0.110
Why?
Obsessive Behavior
1
2010
3
0.110
Why?
Logistic Models
3
2017
777
0.110
Why?
Cognition
1
2015
538
0.110
Why?
Menstrual Cycle
1
2010
36
0.110
Why?
Primary Health Care
1
2012
152
0.110
Why?
Nervous System Diseases
1
2010
34
0.110
Why?
Factor Analysis, Statistical
1
2010
78
0.110
Why?
Physical Therapy Modalities
1
2010
73
0.110
Why?
Fetus
1
2010
73
0.110
Why?
Urban Population
1
2011
78
0.110
Why?
Behavior Therapy
1
2010
88
0.100
Why?
Hormone Replacement Therapy
2
2015
88
0.100
Why?
Cognition Disorders
2
2015
415
0.100
Why?
Mental Disorders
1
2010
100
0.100
Why?
Health Personnel
1
2010
109
0.100
Why?
Confidence Intervals
1
2009
147
0.100
Why?
Analgesics
1
2010
124
0.100
Why?
Medroxyprogesterone Acetate
1
2009
89
0.100
Why?
Multicenter Studies as Topic
1
2009
99
0.100
Why?
Contraceptives, Oral
1
2008
20
0.100
Why?
Biomedical Research
1
2010
163
0.090
Why?
Psychometrics
1
2009
137
0.090
Why?
Teaching
1
2009
55
0.090
Why?
Frail Elderly
1
2009
62
0.090
Why?
Cost-Benefit Analysis
2
2011
155
0.090
Why?
Rural Population
1
2011
337
0.090
Why?
Regression Analysis
1
2009
306
0.090
Why?
European Continental Ancestry Group
1
2013
1356
0.090
Why?
Pregnancy Outcome
1
2008
48
0.090
Why?
Canada
2
2017
50
0.090
Why?
Patient Compliance
1
2009
213
0.080
Why?
Dementia
1
2009
217
0.080
Why?
Endometriosis
1
2007
66
0.080
Why?
Diabetes Complications
1
2008
202
0.080
Why?
Postmenopause
2
2009
407
0.080
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2006
38
0.080
Why?
Analysis of Variance
2
2009
489
0.080
Why?
Videotape Recording
1
2005
12
0.080
Why?
Epilepsy
1
2005
51
0.070
Why?
Carotid Arteries
1
2005
112
0.070
Why?
Statistics as Topic
2
2015
106
0.070
Why?
Aging
2
2009
920
0.070
Why?
Warfarin
2
2017
31
0.070
Why?
Survivors
2
2017
155
0.070
Why?
Atherosclerosis
2
2013
790
0.070
Why?
Patient Satisfaction
2
2018
217
0.070
Why?
Socioeconomic Factors
2
2017
438
0.070
Why?
Guideline Adherence
2
2017
105
0.070
Why?
Double-Blind Method
2
2015
537
0.070
Why?
Oxidative Stress
1
2005
257
0.060
Why?
Embolism
1
2002
7
0.060
Why?
Ethnic Groups
1
2005
544
0.060
Why?
Acute Disease
1
2002
240
0.060
Why?
Reproducibility of Results
2
2014
724
0.060
Why?
Organ Size
2
2014
220
0.060
Why?
Neuropsychological Tests
2
2015
399
0.060
Why?
Inflammation
2
2015
512
0.060
Why?
Health Care Surveys
1
2002
187
0.060
Why?
Academic Medical Centers
1
2002
153
0.060
Why?
Body Mass Index
2
2015
907
0.050
Why?
Myocardial Infarction
1
2004
483
0.050
Why?
Patient Care Team
2
2012
122
0.050
Why?
Diabetes Mellitus
1
2002
426
0.050
Why?
Aftercare
1
2019
25
0.050
Why?
Telephone
1
2019
50
0.050
Why?
Republic of Korea
1
2018
7
0.050
Why?
Preconception Care
1
2017
2
0.050
Why?
Pregnancy in Diabetics
1
2017
2
0.050
Why?
Postnatal Care
1
2017
5
0.050
Why?
Social Behavior
1
2018
65
0.040
Why?
Cost of Illness
1
2018
62
0.040
Why?
Diabetes, Gestational
1
2017
14
0.040
Why?
Coronary Stenosis
1
2017
37
0.040
Why?
Government Programs
1
2017
3
0.040
Why?
Federal Government
1
2017
13
0.040
Why?
International Normalized Ratio
1
2017
6
0.040
Why?
Pyridones
1
2017
10
0.040
Why?
Counseling
1
2017
84
0.040
Why?
Fertility Agents
1
2017
1
0.040
Why?
Disease Management
1
2018
132
0.040
Why?
Contraception
1
2017
11
0.040
Why?
Infertility
1
2017
13
0.040
Why?
Hospitals, Teaching
1
2017
26
0.040
Why?
Pyrazoles
1
2017
64
0.040
Why?
Diabetic Angiopathies
1
2017
158
0.040
Why?
Attitude of Health Personnel
1
2018
164
0.040
Why?
Health Services Research
1
2017
70
0.040
Why?
Chi-Square Distribution
1
2017
315
0.040
Why?
Gene Products, tat
1
2015
1
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
2015
18
0.040
Why?
Stress, Psychological
1
2018
211
0.040
Why?
Mental Status Schedule
1
2015
25
0.040
Why?
Survival Rate
1
2018
855
0.040
Why?
Multivariate Analysis
1
2017
699
0.040
Why?
Inflammation Mediators
1
2015
100
0.040
Why?
Erythroblasts
1
2014
1
0.040
Why?
Megakaryocytes
1
2014
3
0.040
Why?
Child
2
2011
2010
0.040
Why?
Health Knowledge, Attitudes, Practice
1
2018
340
0.040
Why?
Vascular Resistance
1
2014
33
0.040
Why?
Gene Regulatory Networks
1
2014
35
0.040
Why?
Work
1
2014
6
0.040
Why?
Retirement
1
2014
11
0.030
Why?
Sample Size
1
2014
39
0.030
Why?
Models, Organizational
1
2014
21
0.030
Why?
Molecular Sequence Data
1
2014
339
0.030
Why?
Neutrophils
1
2014
104
0.030
Why?
Heart Diseases
1
2014
111
0.030
Why?
Age Distribution
1
2013
204
0.030
Why?
Monocytes
1
2014
114
0.030
Why?
Transcription Factors
1
2014
187
0.030
Why?
Sensitivity and Specificity
1
2014
533
0.030
Why?
Specialties, Nursing
1
2012
1
0.030
Why?
Interviews as Topic
1
2013
320
0.030
Why?
Residence Characteristics
1
2013
164
0.030
Why?
alpha-Galactosidase
1
2011
3
0.030
Why?
Ticlopidine
1
2011
18
0.030
Why?
RNA
1
2011
76
0.030
Why?
Protein Processing, Post-Translational
1
2011
71
0.030
Why?
Social Class
1
2011
73
0.030
Why?
Advisory Committees
1
2010
34
0.030
Why?
Up-Regulation
1
2011
205
0.030
Why?
Emergencies
1
2010
43
0.030
Why?
Brain Injuries
1
2010
89
0.030
Why?
Statistics, Nonparametric
1
2009
139
0.020
Why?
Drug Administration Schedule
1
2009
273
0.020
Why?
Dose-Response Relationship, Drug
1
2009
670
0.020
Why?
Reference Values
1
2007
243
0.020
Why?
Headache
1
2007
82
0.020
Why?
Continental Population Groups
1
2007
249
0.020
Why?
Oximes
1
2004
6
0.020
Why?
Heart Failure
1
2011
633
0.020
Why?
Piperidines
1
2004
121
0.020
Why?
Smoking
1
2007
460
0.020
Why?
Attitude to Health
1
2004
142
0.020
Why?
Survival Analysis
1
2004
475
0.020
Why?
Cross-Sectional Studies
1
2007
1370
0.020
Why?
Hispanic Americans
1
2011
1127
0.020
Why?
Animals
1
2011
7519
0.010
Why?
Bushnell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (347)
Explore
_
Co-Authors (16)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_